Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard 2 Boardroom® staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Early Diagnostic Test for Hypertensive Disorders of Pregnancy

Hypertensive disorders of pregnancy, such as preeclampsia, are estimated to affect between 4-10% of all pregnant women. If left untreated, preeclampsia leads to the development of eclampsia, which is characterized by seizures, cardiac arrest, and kidney failure. Despite the common occurrence of preeclampsia, there is still no known cure or test to assess risk at an early stage of pregnancy. This technology by researchers at the University of Missouri-Columbia encompasses both a new test to determine the risks of preeclampsia in a mother as well as a new potential treatment option to lower the risk of preeclampsia symptoms.


  • Determine risk of pre-eclampsia and other hypertensive disorders in pregnant women
  • Provide treatment to reduce risks of hypertensive disorders of pregnancy


  • Can be used as standalone test or in combination with other tests already on market for more accurate results
  • Based on a novel understanding of cause of pre-eclampsia, this test is more accurate than the current diagnostic options available to pregnant women

Additional Details


University of Missouri - Columbia

Intellectual Property Protection


Interested? Request More Information